Keywords: allergan, bids, 230m, oculex, usa-based, skin, eye

Allergan bids $230M for Oculex

Article | 20 October 2003

Print This

Allergan, the USA-based skin and eye care firm behind the top-selling cosmetic surgery drug Botox (botulinum toxin type-a), says that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in